Philadelphia, PA – April 14, 2011 – DAKOTACARE, a South Dakota managed care organization, owned by the South Dakota State Medical Association and focused on keeping patient care decisions in the hands of physicians, has contracted to implement ITA Partners’ proprietary web-based oncology decision-support platform – eviti – across its comprehensive local network of physicians. ITA Partners is an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care.
Quality in health care is DAKOTACARE’s number one priority – with the added benefit that the highest quality oncology care is often the lowest cost care, in the long run. “We continue to seek innovative options to give our providers greater ability to more effectively manage treatment options for the patient. eviti gives providers access to the most comprehensive knowledge library of evidence-based cancer treatment for all cancer types, ensuring the highest quality of care for the patient,” said Dr. Paul Amundson, DAKOTACARE Chief Medical Officer. “eviti will help increase efficiencies for our providers and allow for quicker authorizations of care, ultimately leading to improved outcomes for our members.”
Click to read more
“eviti streamlines system-wide processes for the delivery of high-quality, cost-effective care to cancer patients, and will greatly improve the information flow between DAKOTACARE and its providers,” said Eduardo Beruff, Chief Executive Officer and President of ITA Partners.
All of the participants in the cancer care process benefit from eviti’s collaborative, real-time approach to improving care and lowering risks and costs:
- Patients benefit from appropriate treatment for their cancer;
- Physicians gain systematic access to the latest, most comprehensive evidence-based treatment standards and clinical decision-support tools, as well as streamlined reimbursement;
- Payers are assured that members are receiving cost-effective care within the scope of their plan benefits.
eviti was launched nationally in October 2010 to provide payer organizations and providers enhanced access to the best cancer treatment decision support available and to advance their performance in the delivery of quality care.
